Skip to content

DR. ANN DE SWERDT

Active
Private limited companyfounded 2009active for 16 yearsLiersebaan 41, 2240 Zandhoven, BelgiumKBO/BCE: BE 0821.286.231

From the official registers: KBO 16 annual accounts at the National Bank publications in the Belgian Official Gazette

Summary

DR. ANN DE SWERDT has been active since 2009 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €177,517 and a net result of €17,939. Equity has been shrinking by about 3.3% per year since 2018. Its solvency ranks better than 95% of 20,678 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).

Overview

Official details

KBO
Status
Active since 10-12-2009 Normal situation
Activity
Specialist medical practice NACE 86220
Establishment unit
2.183.822.960 2240 Zandhoven, since 01-01-2010
Financial year end
31 December
Peppol
Reachable

Board and ownership

Board

Financial position

94 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
< 0.1%
Annual accounts 2025
Gross margin
€107,039
▲ 10.4%
Turnover
≈ €200,000
estimated
Profit
€17,939
▼ 28.8%
Equity
€177,517
▼ 1.6%
Total assets
€181,013
▼ 18.1%
Staff
≈ 0.3 FTE
estimated
Filed on 10-07-2026, 21 days before the deadlineat the National Bank
Score breakdownlowers riskSector: Human health activities (NACE 86)Liquidity: current ratio 35.88, cash €70,057, halvedEquity €177,517 (98.1% of total assets)Figures for financial year 2025 (filed on 10-07-2026)Show the evidence

Checked score

Score 2025
94 / 100
Excellent
Probability in this band: under 0.55%
Financially stronger than 53% of micro companies in human health (NACE 86)
Financial strength · tick: 2024
Strong
Solvency 100=
equity 98.1% of total assets
Liquidity 98+3
short-term debt 1.9% · cash 38.7%
Profitability 46-9
return on assets 9.9%
Bankruptcy probability within 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (24,155 companies, NACE 86, micro)
Last 24 months 11-2024: < 0.1% 12-2024: < 0.1%● unchanged vs 11-2024 01-2025: < 0.1%● unchanged vs 12-2024 02-2025: < 0.1%● unchanged vs 01-2025 03-2025: < 0.1%● unchanged vs 02-2025 04-2025: < 0.1%● unchanged vs 03-2025 05-2025: < 0.1%● unchanged vs 04-2025 06-2025: < 0.1%● unchanged vs 05-2025 07-2025: < 0.1%● unchanged vs 06-2025 08-2025: < 0.1%● unchanged vs 07-2025 09-2025: < 0.1%● unchanged vs 08-2025 10-2025: < 0.1%● unchanged vs 09-2025 11-2025: < 0.1%● unchanged vs 10-2025 12-2025: < 0.1%● unchanged vs 11-2025 01-2026: < 0.1%● unchanged vs 12-2025lowest value 02-2026: < 0.1%● unchanged vs 01-2026 03-2026: < 0.1%● unchanged vs 02-2026 04-2026: < 0.1%● unchanged vs 03-2026 05-2026: < 0.1%● unchanged vs 04-2026 06-2026: < 0.1%● unchanged vs 05-2026 07-2026: < 0.1%● unchanged vs 06-2026 08-2026: < 0.1%● unchanged vs 07-2026highest value 09-2026: < 0.1%● unchanged vs 08-2026highest value 10-2026: < 0.1%● unchanged vs 09-2026highest value
Credit of up to €16,000 on 30-day terms is acceptable
Liquidity is ample, with a current ratio of 35.88 (3.81 in 2024), above the usual 1.5. Short-term debt is 1.9% and cash 38.7% of total assets. 1.9% of the assets are financed with debt and provisions.
Calculation

The band follows from the bankruptcy probability. 10 more points roughly halve it.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro). It does better than 82% of them on solvency, 88% on liquidity, 7% on profitability and 33% on growth.

The bankruptcy probability was computed on 31-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Five signals.
lowers riskneutral
lowers risk · Sector: Human health activities (NACE 86)
KBO
lowers risk · Liquidity: current ratio 35.88, cash €70,057, halved
NBB · annual accounts
lowers risk · Equity €177,517 (98.1% of total assets)
NBB · annual accounts
lowers risk · Figures for financial year 2025 (filed on 10-07-2026)
NBB · annual accounts
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 10-07-2026, 21 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
21 days early
2024
35 days early
2023
6 days late
2022
42 days early
2021
18 days early
2020
26 days late
2019
84 days late
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

The company filed its last 7 accounts on average on the deadline day. In the sector (NACE 86), the median for financial year 2024 was 7 days before the deadline, and 36% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 10 July (5 of the last 5 accounts filed within 30 days either side of that date).
Companies Code · seven months
Where today falls in the filing period
01-11-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
That holds for every publication since 2021.
KBO publications

Key points

  • Positive: Higher solvency than 95% of companies in human healthsector median 63.0% · 20,678 companies 98.1% View

Comparable companies

These companies have the same main activity as DR. ANN DE SWERDT: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €162,000 and €196,000, founded between 2008 and 2012.

CompanyTotal assetsGross margin
DR. ANN DE SWERDT Zandhoven€181,013€107,039
GYORGY TOTH ORTHOPEDISTE Wanze€193,172€105,004
Docteur Tessa GOETGHEBUER, pédiatre Sint-Pieters-Woluwe€193,382€105,878
ANAESTHESIA Dr PATRICK VAN der ELST Rixensart€161,889€103,149
DOCTEUR ERIK VAN HOORDE Montigny-le-Tilleul€178,873€115,706
SONIGRIM Villers-la-Ville€195,165€97,212
DR. OPPERMAN Diksmuide€195,937€107,929
Full comparison

Documents

Annual accounts at the NBB

All 16 annual accounts

Articles and registers

Key facts about DR. ANN DE SWERDT

What is the company number of DR. ANN DE SWERDT?
The company number of DR. ANN DE SWERDT is 0821.286.231. The VAT number is the same number with BE in front: BE 0821.286.231.
Where is DR. ANN DE SWERDT based?
The registered office is at Liersebaan 41, 2240 Zandhoven.Company details
What does DR. ANN DE SWERDT do?
According to the KBO register, the main activity is specialist medical practice (NACE 86220).
What is the legal form of DR. ANN DE SWERDT?
The legal form of DR. ANN DE SWERDT is Private limited company (BV).
When was DR. ANN DE SWERDT founded?
DR. ANN DE SWERDT was founded on 10-12-2009.
Is DR. ANN DE SWERDT still active?
Yes, DR. ANN DE SWERDT is an active enterprise in the KBO register.
How many employees does DR. ANN DE SWERDT have?
DR. ANN DE SWERDT had an average of 0.9 full-time equivalents in financial year 2018, according to the filed annual accounts.Financials
What is the turnover of DR. ANN DE SWERDT?
The turnover in financial year 2025 is ≈ €200,000. This figure is estimated from the gross margin of €107,039 and 43 comparable companies (NACE 86220). It probably lies between €170,000 and €260,000.
Is DR. ANN DE SWERDT profitable?
In financial year 2025, DR. ANN DE SWERDT made a profit of €17,939.
Where can I find the annual accounts of DR. ANN DE SWERDT?
DR. ANN DE SWERDT filed 16 annual accounts with the National Bank of Belgium, the latest for financial year 2025.Annual accounts at the National Bank
When are the next annual accounts of DR. ANN DE SWERDT due?
DR. ANN DE SWERDT must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.